Collectively, combining the expression of human B4GALNT2 with inhibiting viral RNA or protein synthesis could render chickens resistant to multiple virus infections in two ways: B4GALNT2 reduces the initial binding of multiple viruses to cells, increasing cell survivability, and blocking viral RNA or protein synthesis efficiently inhibits viral replication. Here, B4GALNT2 is linked to viral infectious disease.